PlainRecalls
FDA Drug Low Class III Terminated

Eptifibatide Injection, 75 mg/100 mL (0.75 mg/mL), 100 mL Single-use Vial, For Intravenous Use Only, Rx Only, Manufactured by: Akorn Inc., Lake Forest, IL 60045, NDC 17478-903-90.

Reported: September 4, 2019 Initiated: August 6, 2019 #D-1840-2019

Product Description

Eptifibatide Injection, 75 mg/100 mL (0.75 mg/mL), 100 mL Single-use Vial, For Intravenous Use Only, Rx Only, Manufactured by: Akorn Inc., Lake Forest, IL 60045, NDC 17478-903-90.

Reason for Recall

Short Fill: fill volume was out of specification at 94 mL (specification: no less than 100 mL) and Failed Impurities/Degradation Specifications: Out of Specification (OOS) for known impurity, D-aspartic acid.

Details

Recalling Firm
Akorn, Inc.
Units Affected
648 vials
Distribution
Nationwide in the U.S.
Location
Lake Forest, IL

Frequently Asked Questions

What product was recalled?
Eptifibatide Injection, 75 mg/100 mL (0.75 mg/mL), 100 mL Single-use Vial, For Intravenous Use Only, Rx Only, Manufactured by: Akorn Inc., Lake Forest, IL 60045, NDC 17478-903-90.. Recalled by Akorn, Inc.. Units affected: 648 vials.
Why was this product recalled?
Short Fill: fill volume was out of specification at 94 mL (specification: no less than 100 mL) and Failed Impurities/Degradation Specifications: Out of Specification (OOS) for known impurity, D-aspartic acid.
Which agency issued this recall?
This recall was issued by the FDA Drug on September 4, 2019. Severity: Low. Recall number: D-1840-2019.